Wall Street's Most Accurate Analysts Say Hold These 3 Real Estate Stocks With Over 9% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Here's a look at the most recent high-yield dividend stock ratings from the most accurate Wall Street analysts, according to Benzinga's Analyst Stock Ratings.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.

OUTFRONT Media Inc. OUT

Dividend Yield: 10.68%
Morgan Stanley analyst Benjamin Swinburne maintained an Equal-Weight rating and cut the price target from $18 to $15 on Aug. 7, 2023. This analyst has an accuracy rate of 73%.
Oppenheimer analyst Ian Zaffino downgraded the stock from Outperform to Perform on Aug. 4, 2023. This analyst has an accuracy rate of 71%.
Recent News: Outfront Media reported worse-than-expected second-quarter financial results.

SL Green Realty Corp. SLG

Dividend Yield: 9.57%
B of A Securities analyst James Feldman maintained a Neutral rating and raised the price target from $27 to $36 on Aug. 8, 2023. This analyst has an accuracy rate of 61%.
Morgan Stanley analyst Ronald Josey reiterated an Equal-Weight rating with a price target of $21 on July 24, 2023. This analyst has an accuracy rate of 70%.
Recent News: SL Green reported lower-than-expected second-quarter earnings results.

Sabra Health Care REIT, Inc. SBRA

Dividend Yield: 9.75%
Citigroup analyst Nicholas Joseph maintained a Neutral rating and raised the price target from $11 to $12.5 on July 14, 2023. This analyst has an accuracy rate of 63%.
Credit Suisse analyst Omotayo Okusanya reiterated a Neutral rating with a price target of $13 on April 12, 2023. This analyst has an accuracy rate of 61%.
Recent News: Sabra Health Care posted downbeat quarterly sales.